Report Categories
View AllRecent Articles
View All
Assoc Banc ASBA Entry Point 131 EPS Beat for Associated BancCorp 2033 Notes
The key risks discussed in Tvardi Therapeutics TVRD earnings Q4 2025 EPS Misses Views
Why HCM III HCMAW leadership matters more than you think 440 20260508
International Business Machines Corporation IBM Faces Escalating Legal Headwinds Amid DEI Policy Shifts
COMP Compass delivers narrower Q4 2025 loss than analyst estimates shares slide 238 percent today
IPI Intrepid Potash posts 47 percent Q4 2025 EPS beat yet shares drop 134 percent in todays trading
DTST Data Storage posts massive Q4 2025 EPS beat shares decline 233 percent in todays trading session
The balance sheet strength behind Simpson SSD results Q1 2026 EPS Tops Views
Skyward SKWD Q1 2026 Earnings Surprise EPS 125 Up Significant
Caturus Takes Final Investment Decision on 13bn Commonwealth LNG Project in Louisiana
Bond Market Signals Inflation Concerns as New Fed Chair Warsh Takes Helm
Political Executions Surge in Iran Since Late February UN Confirms at Least 32 Cases
Genpact CEO Suggests AI Could Reduce IT Workload and Slow Job Growth
The AI Economy Reshapes the American Dream BlueCollar Workers May Emerge as Winners
Leonardo Secures 320 Million Deal to Equip Kuwaiti Patrol Vessels
Apples Record High Rally Faces Key Test at June WWDC as AI Strategy Takes Center Stage
Corporate Interest in Prediction Markets Remains Strong Despite Regulatory Uncertainty
IREN and Dell Technologies Announce 16 Billion AI Infrastructure Partnership
BOOM Q1 2026 Earnings EPS Surprises to the Upside Despite Loss
WTS Q1 2026 Earnings Strong EPS Beat Drives Positive Market Response
MeiraGTx Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Advances Pipeline
Velocity Financial Q1 2026 Earnings EPS Beat Fails to Boost Stock
HAFN Q4 2025 Earnings EPS Misses Estimates as Tanker Market Softens
Hoyne Bancorp Inc HYNE Edges Higher Amid Steady Trading
NewAmsterdam Pharma NAMS Slightly Lower Amid Consolidation Near Key Support Levels
Citius Pharmaceuticals CTXR Holds Near Support as Selling Pressure Eases
Nektar Therapeutics NKTR Fades 287 as Biotech Stock Tests Key Support Levels